201 related articles for article (PubMed ID: 16511411)
21. [Polymorphism of regulated upon activation, normal T cell expressed and secreted promoter region -28 position in Chinese allergic asthmatic children].
Wang LJ; Li YR; Chen JH; Cui TP; Wu JM
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):394-7. PubMed ID: 15256089
[TBL] [Abstract][Full Text] [Related]
22. Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression.
Daar ES; Lynn HS; Donfield SM; Lail A; O'Brien SJ; Huang W; Winkler CA;
J Infect Dis; 2005 Nov; 192(9):1597-605. PubMed ID: 16206074
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus.
Liao CH; Yao TC; Chung HT; See LC; Kuo ML; Huang JL
J Rheumatol; 2004 Oct; 31(10):2062-7. PubMed ID: 15468376
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
Collazos J; Asensi V; Cartón JA
AIDS; 2007 Apr; 21(7):835-43. PubMed ID: 17415038
[TBL] [Abstract][Full Text] [Related]
25. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
26. RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection.
Krüger B; Böger CA; Obed A; Farkas S; Hoffmann U; Banas B; Fischereder M; Krämer BK
Clin Transplant; 2007; 21(3):385-90. PubMed ID: 17488389
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
Morawetz RA; Rizzardi GP; Glauser D; Rutschmann O; Hirschel B; Perrin L; Opravil M; Flepp M; von Overbeck J; Glauser MP; Ghezzi S; Vicenzi E; Poli G; Lazzarin A; Pantaleo G
Eur J Immunol; 1997 Dec; 27(12):3223-7. PubMed ID: 9464809
[TBL] [Abstract][Full Text] [Related]
28. Mannose-binding lectin in susceptibility and progression of HIV-1 infection in children.
Dzwonek A; Novelli V; Bajaj-Elliott M; Turner M; Clapson M; Klein N
Antivir Ther; 2006; 11(4):499-505. PubMed ID: 16856624
[TBL] [Abstract][Full Text] [Related]
29. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
30. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
[TBL] [Abstract][Full Text] [Related]
31. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study.
McDermott DH; Beecroft MJ; Kleeberger CA; Al-Sharif FM; Ollier WE; Zimmerman PA; Boatin BA; Leitman SF; Detels R; Hajeer AH; Murphy PM
AIDS; 2000 Dec; 14(17):2671-8. PubMed ID: 11125885
[TBL] [Abstract][Full Text] [Related]
32. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
33. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression.
Oh DY; Baumann K; Hamouda O; Eckert JK; Neumann K; Kücherer C; Bartmeyer B; Poggensee G; Oh N; Pruss A; Jessen H; Schumann RR
AIDS; 2009 Jan; 23(3):297-307. PubMed ID: 19114863
[TBL] [Abstract][Full Text] [Related]
34. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
35. RANTES promoter genotype and gastric cancer risk in a Japanese population.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Hirata I; Arisawa T
Anticancer Res; 2009 Oct; 29(10):4265-9. PubMed ID: 19846984
[TBL] [Abstract][Full Text] [Related]
36. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
37. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity.
Sandford AJ; Chagani T; Zhu S; Weir TD; Bai TR; Spinelli JJ; Fitzgerald JM; Behbehani NA; Tan WC; Paré PD
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):135-40. PubMed ID: 10887316
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
40. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
Chiappini E; Galli L; Tovo PA; Gabiano C; Gattinara GC; Guarino A; Badolato R; Giaquinto C; Lisi C; de Martino M;
AIDS; 2006 Jan; 20(2):207-15. PubMed ID: 16511413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
